|
Mr. Jungles joined BioMarin in June 1999 and currently serves as vice president of supply chain. His responsibilities include oversight of planning, warehousing, manufacturing support, contract manufacturing and distribution functions for the company's clinical and commercial products. Prior to coming to BioMarin, Mr. Jungles served as Associate Director of Manufacturing and Operations at the Harvard Gene Therapy Initiative, where he was responsible for the clinical manufacturing of recombinant viral vectors and the supervision of Manufacturing, Quality Control, Quality Assurance, Operations and support staff. From 1993 to 1997, Mr. Jungles acted as manager of process development and clinical production at Somatix Therapy Corporation and oversaw process development and large scale cGMP production of cellular vaccines. Earlier in his career, he was involved in process development-related positions at Hygeia Pharmaceuticals, Inc., and the Hyland Division of Baxter. Mr. Jungles received a B.S. in Biology from the University of Iowa and holds a California State Board of Pharmacy Exemptee Certificate for the manufacture of dangerous drugs. | 